US 12,465,257 B2
Method and device for reproducible placement of ECG chest electrodes
Heikki Riekkinen, Kuopio (FI); Tommi Riekkinen, Kuopio (FI); and Annika Kolari, Kuopio (FI)
Assigned to BIOPOTENTIAL Oy Ltd, Kuopio (FI)
Appl. No. 17/782,553
Filed by BIOPOTENTIAL Oy Ltd, Kuopio (FI)
PCT Filed Dec. 4, 2020, PCT No. PCT/EP2020/084679
§ 371(c)(1), (2) Date Jun. 3, 2022,
PCT Pub. No. WO2021/110937, PCT Pub. Date Jun. 10, 2021.
Claims priority of application No. 20196062 (FI), filed on Dec. 5, 2019.
Prior Publication US 2023/0017159 A1, Jan. 19, 2023
Int. Cl. A61B 5/24 (2021.01); A61B 5/00 (2006.01)
CPC A61B 5/24 (2021.01) [A61B 5/68 (2013.01); A61B 2562/0209 (2013.01)] 20 Claims
OG exemplary drawing
 
1. A method for positioning of six ECG electrodes for precordial leads V1-V6 on a human subject based on the subject's body height, characterised in that the method comprises the steps of
(i) determining the horizontal level of the electrodes for leads V4, V5 and V6 (102, 703), wherein the horizontal level (102, 703) is deter-mined to be between (0.088×body height) [cm] and (0.092×body height) [cm] downwards from the sternal notch (701) along the ster-nal midline (101, 702);
(ii) marking the position of the electrode for lead V1 (104, 708) from 2.8 cm to 3 cm above the horizontal level (102, 703) along the sternal midline (101, 702), and from 2.9 cm to 3.5 cm to the subject's right from the sternal midline (101, 702);
(iii) marking the position of the electrode for lead V2 (105, 709) from 2.8 cm to 3 cm above the horizontal level (102, 703) along the sternal midline (101, 702), and from 2.9 cm to 3.5 cm to the subject's left of the sternal midline (101, 702);
(iv) marking the position for the electrode for lead V4 (107, 704) at the horizontal level (102, 703) and (body height/16)±1 [cm] to the subject's left from the sternal midline (101, 702) along the surface of the thorax;
(v) marking the position for the electrode for lead V3 (106) from (0.023×body height) [cm] to (0.025×body height) [cm] from the position of the electrode for lead V2 (105, 709) to the direction of the position for the electrode for lead V4 (107, 704) along the connecting line formed by the position of the electrode for lead V2 (105, 709) and the position of the electrode for lead V4 (107, 704);
(vi) marking the position for the electrode for lead V5 (705) at the hori-zontal level (102, 703) and ((3×body height)/32)+1 [cm] to the subject's left from the sternal midline (101, 702) along the surface of the thorax;
(vii) marking the position for the electrode for lead V6 (706) at the hori-zontal level (102, 703) and (body height/8)±1 [cm] to the subject's left from the sternal midline (101, 702) along the surface of the thor-ax; and
(viii) positioning the six ECG electrodes for precordial leads V1-V6 at the positions identified in steps (ii) to (vii);
wherein the method is carried out on the same subject on at least two different time points.